Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFASITAMAB vs TALC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFASITAMAB vs TALC: Safety Overview

Metric TAFASITAMAB TALC
Total FAERS Reports 1,392 933
Deaths Reported 475 222
Death Rate 34.1% 23.8%
Hospitalizations 433 69
Average Patient Age 70.0 yrs 56.6 yrs
% Female Patients 50.1% 79.6%
FDA Approval Date N/A Dec 15, 2003
Manufacturer Incyte Corporation Novatech SA
Route INTRAVENOUS INTRAPLEURAL
Marketing Status N/A Prescription